Stanford Downgrades Zimmer Holdings (ZMH) to Hold
More News related to ZMH
- Zimmer Holdings to Present at 27th Annual JP Morgan Healthcare Conference
- Zimmer Holdings (ZMH) volume & volatility increase
- FDA Approval Granted on New Titanium Dental Implant
- Zimmer Holdings Names Jeffery A. McCaulley President, Zimmer Reconstructive
- Morgan Stanley Downgrades Zimmer Holdings (ZMH) to Underweight
More News related to Downgrades
- ARGUS Downgrades Smith International (SII) to Hold
- Cantor Fitzgerald Downgrades Audiocodes (AUDC) to Hold After Negative 4Q Preannouncement
- MDB Capital Downgrades Ener1 (HEV) to Sell, Suspends Earnings Model and Valuation on Stock No Longer Justified
- DA Davidson Downgrades Ambassadors Group (EPAX) to Neutral
- SunTrust Downgrades Ruby Tuesday, Inc. (RT) to Neutral
Stanford Group downgrades Zimmer Holdings (NYSE: ZMH) from Buy to Hold.
Zimmer Holdings, Inc. and its subsidiaries design, develop, manufacture, and market reconstructive orthopaedic implants in the Americas, Europe, and Asia Pacific.
Related Categories
DowngradesStocks Mentioned
+1.08Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
